Anterix Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: -7.72%

Anterix Inc. Return on Equity (ROE) is -7.72% for the Trailing 12 Months (TTM) ending March 31, 2025, a 46.02% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Anterix Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was -5.29%, a -44.96% change year over year.
  • Anterix Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was -9.61%, a -60.02% change year over year.
  • Anterix Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was -24.03%, a -1.42% change year over year.
  • Anterix Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was -24.37%, a 51.74% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share